title: Is HIV-1C a risk factor for protease inhibitor failure?
authors.affiliation: Division of Medical Virology, Department Pathology, Stellenbosch University, Faculty of Medicine and Health Sciences, Parow, Cape Town 8000, South Africa; National Health Laboratory Services, Tygerberg, Cape Town, South Africa. Electronic address: guvz@sun.ac.za.
authors.forename: Gert U
authors.initials: GU
authors.lastname: van Zyl
authors.affiliation: Division of Clinical Pharmacology, Department Medicine, Stellenbosch University, Faculty of Medicine and Health Sciences, Parow, Cape Town, South Africa.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Decloedt
mesh_terms: D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D012307:Risk Factors
chemical_list: D017320:HIV Protease Inhibitors